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ABSTRACT 
Background and Objectives: Percutaneous occlusion of patent ductus arteriosus (PDA) has become increasingly 
attractive with the evolution of devices and techniques. We reviewed results for percutaneous occlusion of PDA 
using various devices in a single center. Subjects and Methods: A retrospective review was done for 118 consecu-
tive procedures performed in 111 patients with PDA between January 1996 and December 2007. Results: The 
median age of the patients was 4.5 years (0.9 to 60.3 years); body weight was 16.9 kg (6.8 to 74.7 kg). The median 
PDA diameter at the pulmonic end was 3.8 mm (0.7 to 10 mm); mean pulmonary artery pressure was 21.0 mmHg 
(7 to 60 mmHg). Complete occlusion occurred in 76/111 (68.4%) immediately after implantation and in 100/111 
(90.0%) at one year of follow-up. Second procedures for residual shunts were done in 7 patients. After the year 
2001, the complete closure rate was 95.2% compared to 71.4% before 2001. Complications associated with the pro-
cedure were left pulmonary artery narrowing (all <20 mmHg) in 14, arrhythmia in 2, and death in 1. Conclusion: 
Evolution of devices, cumulative experience, and health insurance covering the cost of devices have contributed 
to good outcomes in our center for percutaneous occlusion of PDA. Our results have improved over the years, 
particularly with the use of the Amplatzer duct occluder. (Korean Circ J 2010;40:230-234) 
 
KEY WORD: Ductus arteriosus, patent. 
 
 
Introduction 
 
Since Rao et al.
1) first reported transcatheter occlusion 
(TCO) of a patent ductus arteriosus (PDA) with an Iv-
alon plug, several other devices have been developed in-
cluding Rashkind double-umbrella (umbrella),
2) Sideris 
buttoned device (SBD),
3) Gianturco coil
4) or Duct-occlud
5) 
device (coil), and an Amplatzer Duct Occluder (ADO).
6) 
We reviewed our experience with TCO of PDA using va-
rious devices to determine the efficacy and safety of TCO 
with regard to rates of success and complications. 
 
Subjects and Methods 
 
Subjects 
A retrospective review was done for 118 consecutive 
procedures performed in 111 patients (31 males, 80 fe-
males) for PDA during the 12 years from January 1996 
to December 2007. Associated anomalies were ventri-
cular septal defect (n=4), atrial septal defect (2), pul-
monary valve stenosis (1), anomalous origin of the left 
coronary artery from the pulmonary artery (1), and 
Down syndrome (3). For TCO of PDA, we used a SBD 
(Custom Medical Devices, Athens, Greece; TX, USA), 
an umbrella (USCI, Billerica, MA, USA), coils such as 
a Gianturco coil (Cook, Inc., Bloomington, IN, USA), 
a Duct-occlud device (PFM, Cologne, Germany), and 
an ADO (AGA, MN, USA). Patients were divided into 
four groups based on the devices that were used: SBD, 
umbrella, coil, and ADO. In our center, SBD was used 
by the year 1997 and umbrella by 1999, both for some-
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what large ductus with big shunts. After 1996, coils were 
favored in cases of a rather small ductus (ductal diameter 
≤2.5 mm) with one or more coils. For secondary occlu-
sion, we mostly used a coil. ADO has been used for 
ductus >2.5 mm (ductal diameter) since 1999 (Table 1).  
 
Procedures and follow up 
The procedure for each device has been reported.
2)3)5)7) 
The ductal diameter was measured at the pulmonic end 
in the lateral aortogram.
8) The residual shunt was iden-
tified by aortogram, 10 to 15 minutes after the implan-
tation of devices. The catheterization data and angio-
grams were reviewed by one examiner (NY Kim). Two-
dimensional echocardiography and Doppler studies were 
performed on the next day, and 3, 6, and 12 months fol-
lowing the procedure. Attention was paid to the residual 
ductal flow and stenosis of the left pulmonary artery and 
the aortic arch.
9)10)  
 
Statistical analysis 
Statistical Package for the Social Sciences (SPSS) for 
Windows (version 12.0, SPSS Inc., Chicago, IL, USA) 
was used for analysis. Comparisons among the four 
groups were done with the Kruskal-Wallis test. Compari-
sons between two groups were done using the Mann-Wh-
itney U-method. A p<0.05 was considered significant. 
 
Results 
 
Comparisons between groups 
SBD (n=7 cases), umbrella (n=5), coil (n=41), and 
ADO (n=58) were used. The patients’ mean age was 
12.5±15.4 years (0.9 to 60.3 years: SBD 14.0±18.7 
years, umbrella 8.9±7.1 years, coil 5.1±6.5 years, ADO 
17.9±17.8 years). Mean weight was 27.0±20.0 kg (6.8 
to 74.7 kg: SBD 26.4±16 kg, umbrella 34.0±27.5 kg, 
coil 18.0±13.9 kg, ADO 32.8±21.3 kg). There was no 
difference between groups in age and weight. The mean 
ductal diameter was 3.81±1.72 mm (0.7 to 10 mm: 
SBD 3.99±1.21 mm, umbrella 4.62±1.10 mm, coil 2.18
±0.82 mm, ADO 4.80±1.41 mm). The ADO group 
had the biggest ductus and the coil group the smallest 
(p<0.01). The ratio of pulmonary blood flow to syste-
mic flow (Qp/Qs) in each group was SBD 2.00±0.94, 
umbrella 1.77±0.82, coil 1.30±0.37, and ADO 1.95
±0.71. The mean pulmonary arterial pressure (m-PAP) 
was 22.6±10.6 mmHg (7 to 60 mmHg: SBD 20.2±
9.79 mmHg, umbrella 18.2±4.23 mmHg, coil 19.5±
8.34 mmHg, and ADO 25.6±11.8 mmHg). There was 
a significant difference in m-PAP only between coil and 
ADO (p<0.01). A total of 24 patients (21.6%) had pul-
monary hypertension (m-PAP >25 mmHg) (Table 1). 
 
Results of the procedures  
Complete occlusion occurred in 76 of 111 patients 
(68.4%) at the first trial. Of 35 patients with residual 
shunt, 25 (71.4%) showed spontaneous occlusion at 1 
year of follow up. Reopening developed during follow 
up in 6 who had an immediate complete closure with a 
coil. Secondary procedures were performed in 7 using 
coils and one underwent an additional operation. The 
final occlusion rate at 1 year of follow up was 90.0% 
(100/111) (Fig. 1). 
 
Sideris buttoned device   
Only 1 of 7 SBDs was implanted successfully. Two 
showed spontaneous occlusion at follow up, 3 had suc-
cessful second procedures with a coil but one of the three 
developed reopening. One was lost to follow up. 
 
Rashkind double umbrella 
Of 5 umbrellas, 1 was inserted uneventfully; 1 patient 
had spontaneous occlusion, 2 had a secondary proce-
dure with success. 
 
Coil 
Coils were used in 41 patients, leading to immediate 
complete occlusion in 27 patients: 5 patients had two 
coils at the first trial; 10 of 14 who had residual shunt 
showed spontaneous occlusion at follow up, and two 
Table 1. Demographic and catheterization data for each device group
Devices  SBD  Umbrella  Coil  ADO  p 
No. patient  7  5  41  58   
Sex ratio (M : F)  1 : 6  1 : 4  13 : 28  16 : 42   
Mean age (year)  14.0±18.7 (1.5-54.2) 8.9±7.1   (3.1-16.8) 5.0±6.4   (0.9-33.7) 17.9±17.8 (0.9-60.3) NS 
Mean weight (kg)  26.4±16.5 (10.1-51.0) 34.0±27.5 (13.3-74.7) 18.0±13.9 (7.4-68.7) 32.8±21.3 (6.8-70.0) NS 
Ductal diameter (mm)  3.99±1.21 4.62±1.10 2.18±0.82 4.80±1.41  <0.001*
Qp/Qs 2.00±0.94 1.77±0.82 1.30±0.37 1.95±0.71  <0.001*
Mean PAP (mmHg)  20.2±9.79 18.2±4.23 19.5±8.34 25.6±11.8  <0.018
†
Immediate occlusion rate (%)  1/7 (14.3)  1/5 (20.0)  27/41 (63.4)  47/58 (81.0)0  
Spontaneous occlusion rate (%)  2/6 (33.3)  2/4 (50.0)  10/14 (71.4)  11/11 (100.0)   
Occlusion rate at 1 year of F/U (%) 3/7 (42.9)  3/5 (60.0)  33/41 (80.5)  58/58 (100.0)   
*Significant differences between coil and other device groups, †Significant difference between coil and ADO groups. Qp/Qs: determination 
of the pulmonary to systemic blood flow ratio, PAP: pulmonary arterial pressure, NS: no significant difference between groups, SBD: Sideris 
buttoned device, ADO: Amplatzer duct occluder, F/U: follow up 
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were lost to follow up. 
 
Amplatzer duct occluder 
ADO was implanted in 58 patients: 81% (47/58) had 
complete occlusion immediately after implantation and 
11 with residual shunt showed spontaneous occlusion 
at follow up. Hence, complete occlusion was achieved in 
all cases. 
 
Complications 
There was left pulmonary artery narrowing of less 
than 20 mmHg in 14 cases, arch obstruction in 2, transi-
ent bradycardia in 1, anemia requiring transfusion in 2, 
embolization of the device in 1, and death in 1 who had 
coil occlusion for ductus with a 2.5 mm of diameter but 
a residual shunt developed immediately after implantat-
ion and progressed to significant hemolytic anemia. A 
second procedure using ADO was planned but sudden 
uncontrollable arrhythmia developed during the proce-
dure, and eventually led to the death of the patient (Ta-
ble 2).  
The impact of health insurance 
Health insurance has been applied to the use of ADO 
since 2001, which has resulted in the lessening of cost 
and a greater use of ADO. This has caused increase in 
the occlusion rate of PDA from 71.4% to 95.2% (Fig. 2). 
 
Discussion 
 
PDA is a common congenital heart disease account-
ing for 10% of all cases of congenital heart disease. Sur-
gical closure of a PDA was a conventional treatment and 
has a negligible mortality rate. However, the morbidity 
of general anesthesia and thoracotomy such as phrenic 
nerve injury, scar formation, and bleeding, has driven the 
search for treatment options that are nonsurgical.
10)13-16) 
In 1967, Porstmann and colleagues introduced a non-
surgical closure of PDA with the use of a preshaped Iv-
alon plug, delivered through the femoral artery and re-
quiring an 18 F sheath for implantation. In 1979, Rash-
kind and Cuaso developed a polyurethane foam disc um-
brella requiring an 8 F or an 11 F sheath. But it is hardly 
applicable in infancy. Furthermore, the device induces a 
high residual leak and fracture of arm discs, and is not 
suitable for tubular shaped or short ductus or ductus >7 
mm in diameter.
9)11-13)17) In 1991, Sideris et al. developed 
an adjustable buttoned device that can be delivered via 
a 7 F sheath, but the device also shows a high residual 
leak and a significant failure rate, especially when the 
ductus has a long conical shape or is large.
1)9)11)18-20) Th-
ereafter, Lloyd and Moore and their coworkers reported 
coil occlusion of PDAs from the arterial side using a 5 
F or a 6 F sheath.
4)7)21) Single or multiple coils are useful 
for small or tubular shaped ductus. Several modifications 
such as retrievable, detachable coils, or use of a nitinol 
Table 2. Procedural complications
  No.
Major complications 
Death  01
Anemia requiring transfusion  02
Significant hemolysis  01
Minor complications 
Mild narrowing of left pulmonary artery (<20 mmHg)  14
Mild narrowing of descending aorta (<20 mmHg)  02
Transient bradycardia  01
Embolization of radio-opaque marker  01
 
Native duct 
111 
Complete 
occlusion 1 
Complete 
occlusion 1 
Complete 
occlusion 47 
Reopen 4
Reopen 1  Reopen 1
Sideris button device 
7 
Amplatzer 
58 
Coil 
41 
Umbrella 
5 
Complete 
occlusion 2 
Residual 
shunt 1 
Complete 
occlusion 2
Complete 
occlusion 1
Death 
1 
Spontaneous
closure 11 
Spontaneous 
closure 2 
Second 
trial 3 
Refuse 
retrial 1 
Spontaneous
closure 2 
Second
trial 2 
Spontaneous
closure 10 
Second
trial 2 
Residual 
1 
Embolization
1 
Residual 
shunt 6 
Residual 
shunt 4 
Complete 
occlusion 27
Residual 
shunt 14 
Residual 
shunt 11 
Fig. 1. Outcomes of transcatheter occlusion of PDA cases with different devices. PDA: patent ductus arteriosus.  
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snare or forcep, has been tried to decrease the rate of  
embolization, a common complication.
9)16)22)23) A Duct-
occlud device was designed to better match the shape 
and configuration of the PDA so that high stability on 
delivery and higher complete closure rates could be 
achieved with a single device.
5)9) Multiple coils sometimes 
cause protrusion of the coil into the left pulmonary ar-
tery or aorta. In 1998, Masura et al.
 9) reported the use of 
ADO for TCO of moderate to large sized PDAs. The de-
vice has the benefit of less embolization, easier implantat-
ion, and a 98% to 100% occlusion rate.
9)24) Our country 
also has spent considerable effort in developing a better 
device and the technology to increase the success rate.
25) 
The results of our study show that the coil group had a 
low Qp/Qs ratio and worked for small ductus but the 
ADO was mostly used for large ductus with higher PAP. 
TCO with an umbrella double disc or a SBD produced a 
low occlusion rate and were discarded, which demonst-
rates that those devices were less effective (the reason might 
be that our center had little experience performing these 
procedures in the early stages of TCO). In the coil group, 
a well designed strategy for determining coil number ac-
cording to ductal diameter would have given a better out-
come. For instance, two or more coils for a ductus >2 mm 
or an immediate trial of a second coil in case of a residual 
shunt. The problems of reopening of a shunt and format-
ion of a central residual shunt in coil TCO remain to be 
solved. Since public health insurance in Korea covers the 
cost of the ADO procedure, the performers have favored 
ADO for a ductus >2.5 mm and eventually the occlusion 
rate reached 100%, although the overall complete occlus-
ion rate is 95.2%. Our study reveals that the success of 
TCO depends on the availability of safe, effective devices 
and an experienced interventionist. Health insurance sup-
port has also greatly affected outcomes.   
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